We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel to Consider Pfizer/BioNTech Booster Shots
FDA Advisory Panel to Consider Pfizer/BioNTech Booster Shots
The FDA announced that it will hold an advisory committee meeting Sept. 17 to discuss the third booster for the Pfizer/BioNTech mRNA COVID-19 vaccine for people age 16 years and older.